White Paper | February 20, 2014

A Model For Pharmaceutical Supply Chain Quality Agreements

Source: Marken
Marken

By Rafik H. Bishara, Steve Jacobs, and Dan Bell

Over a decade ago, the way business was conducted between pharmaceutical manufacturing companies and their supply chain providers was typically expressed through verbal expectations at the due diligence meeting, at the audit, or at the first project meeting, and they were pretty much done by written bullet points.

Today, successful sponsor companies regard the vendor company as a partner. Experienced sponsors expect their partners to be a part of their team. The expectation is that they will guide them in areas where their team members are new, inexperienced, or still learning.

For full access to this content, please Register or Sign In.

Access Content A Model For Pharmaceutical Supply Chain Quality Agreements